Detalles de la búsqueda
1.
Derazantinib, a fibroblast growth factor receptor inhibitor, inhibits colony-stimulating factor receptor-1 in macrophages and tumor cells and in combination with a murine programmed cell death ligand-1-antibody activates the immune environment of murine syngeneic tumor models.
Anticancer Drugs
; 34(9): 1035-1045, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729099
2.
Effectiveness of Self-Help Plus in Preventing Mental Disorders in Refugees and Asylum Seekers in Western Europe: A Multinational Randomized Controlled Trial.
Psychother Psychosom
; 90(6): 403-414, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34350902
3.
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
EMBO Rep
; 19(8)2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29907679
4.
Effectiveness of a WHO self-help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial.
World Psychiatry
; 21(1): 88-95, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35015365
5.
Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.
Cancer Gene Ther
; 28(1-2): 18-26, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32595215
6.
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial.
Trials
; 21(1): 695, 2020 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32746941
7.
Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions.
Nat Commun
; 10(1): 3134, 2019 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31316070
8.
Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials.
BMJ Open
; 9(5): e030259, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31092670
9.
WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response.
Cell Death Dis
; 8(7): e2955, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28749468
10.
The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer.
Mol Cancer Ther
; 16(10): 2246-2256, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28775148
11.
The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.
Cancer Discov
; 2(2): 156-71, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22585860
Resultados
1 -
11
de 11
1
Próxima >
>>